Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oncolytic Viruses Engineered to Enforce Leptin Expression Reprogram Tumor-Infiltrating T Cell Metabolism and Promote Tumor Clearance
Dayana B. Rivadeneira, Kristin DePeaux, Yiyang Wang, et al.
Immunity (2019) Vol. 51, Iss. 3, pp. 548-560.e4
Open Access | Times Cited: 119

Showing 1-25 of 119 citing articles:

Metabolic barriers to cancer immunotherapy
Kristin DePeaux, Greg M. Delgoffe
Nature reviews. Immunology (2021) Vol. 21, Iss. 12, pp. 785-797
Open Access | Times Cited: 381
CD8+ T cell metabolism in infection and cancer
Miguel Reina‐Campos, Nicole E. Scharping, Ananda W. Goldrath
Nature reviews. Immunology (2021) Vol. 21, Iss. 11, pp. 718-738
Open Access | Times Cited: 377
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Adel Naimi, Rebar N. Mohammed, Ahmed Raji, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 278
Nanotechnology for Boosting Cancer Immunotherapy and Remodeling Tumor Microenvironment: The Horizons in Cancer Treatment
Shan Gao, Xiaoye Yang, Jiangkang Xu, et al.
ACS Nano (2021) Vol. 15, Iss. 8, pp. 12567-12603
Closed Access | Times Cited: 177
Oncolytic virotherapy: basic principles, recent advances and future directions
Danni Lin, Yinan Shen, Tingbo Liang
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 163
mTOR signaling at the crossroads of environmental signals and T‐cell fate decisions
Hongling Huang, Lingyun Long, Peipei Zhou, et al.
Immunological Reviews (2020) Vol. 295, Iss. 1, pp. 15-38
Open Access | Times Cited: 144
Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases
Shen Wang, Bo Liang, Weiqi Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 94
Metabolic challenges and interventions in CAR T cell therapy
Jhan-Jie Peng, Limei Wang, Zhiyu Li, et al.
Science Immunology (2023) Vol. 8, Iss. 82
Closed Access | Times Cited: 59
Oncolytic viruses engineered to enforce cholesterol efflux restore tumor-associated macrophage phagocytosis and anti-tumor immunity in glioblastoma
Shiqun Wang, Wei Yan, Lingkai Kong, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 52
Cellular metabolism regulates the differentiation and function of T-cell subsets
Sicong Ma, Yanan Ming, Jingxia Wu, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 5, pp. 419-435
Open Access | Times Cited: 42
Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy
Simona Ruxandra Volovăț, Dragoş Viorel Scripcariu, Ingrid-Andrada Vasilache, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1180-1180
Open Access | Times Cited: 20
Adipokines: masterminds of metabolic inflammation
Herbert Tilg, Gianluca Ianiro, Antonio Gasbarrini, et al.
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 18
CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency
Feng Li, Yuqiao Sheng, Weizhou Hou, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000131-e000131
Open Access | Times Cited: 86
New viral vectors for infectious diseases and cancer
Emanuele Sasso, Anna Morena D’Alise, Nicola Zambrano, et al.
Seminars in Immunology (2020) Vol. 50, pp. 101430-101430
Open Access | Times Cited: 86
The pleiotropic roles of leptin in metabolism, immunity, and cancer
Paola de Candia, Francesco Prattichizzo, S. Garavelli, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 5
Open Access | Times Cited: 84
Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy
Xin Lian, Kailin Yang, Renliang Li, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 67
Remodeling the tumor microenvironment by oncolytic viruses: beyond oncolysis of tumor cells for cancer treatment
Lihong Wang, Louisa S. Chard, Zhenguo Cheng, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 5, pp. e004167-e004167
Open Access | Times Cited: 61
Systems-based approaches to study immunometabolism
Vinee Purohit, Allon Wagner, Nir Yosef, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 3, pp. 409-420
Open Access | Times Cited: 42
Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response
Yi-Ying Wu, Te-Kai Sun, Ming‐Shan Chen, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 32
Emerging mechanisms and promising approaches in pancreatic cancer metabolism
Hao Wu, Mengdi Fu, Mengwei Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 12
Antitumor T-cell Reconditioning: Improving Metabolic Fitness for Optimal Cancer Immunotherapy
Dayana B. Rivadeneira, Greg M. Delgoffe
Clinical Cancer Research (2018) Vol. 24, Iss. 11, pp. 2473-2481
Open Access | Times Cited: 61
Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patients
Biao Huang, Wei Han, Zu-Feng Sheng, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 61
An engineered oncolytic vaccinia virus encoding a single-chain variable fragment against TIGIT induces effective antitumor immunity and synergizes with PD-1 or LAG-3 blockade
Shuguang Zuo, Min Wei, Tiancheng Xu, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 12, pp. e002843-e002843
Open Access | Times Cited: 51
The effects of age and systemic metabolism on anti-tumor T cell responses
Jefte M. Drijvers, Arlene H. Sharpe, Marcia C. Haigis
eLife (2020) Vol. 9
Open Access | Times Cited: 50
Leptin, Both Bad and Good Actor in Cancer
Carlos Jiménez‐Cortegana, Ana López-Saavedra, Flora Sánchez-Jiménez, et al.
Biomolecules (2021) Vol. 11, Iss. 6, pp. 913-913
Open Access | Times Cited: 49
Page 1 - Next Page

Scroll to top